Mink Therapeutics Inc (INKT) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mink Therapeutics Inc   (NASDAQ: INKT)


Mink Therapeutics Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mink Therapeutics Inc's ROI in the third quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Mink Therapeutics Inc 's return on investment (ROI) in its third quarter of 2026

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 2 -13 -14 -14
Return On Investment (TTM) 177.83 % 118.4 % - - -
INKT's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -11 -11 -12 -12 -12

INKT Company Profile >> Back to INKT Roi Comparisons >> See Annual INKT Return On Investment



Return On Investment INKT's Ranking
Within: No.
Industry # 64
Sector # 355
Overall #

Return On Investment Statistics
High Average Low
-137.32 %
-960.74 %
-4247.85 %
(Sep 30 2026)   (Jun 30 2023)







Financial Statements
Mink Therapeutics Inc's III. Quarter Investments $ 0 Millions INKT's Balance sheet
Mink Therapeutics Inc's III. Quarter Income $ -3 Millions Quarterly INKT's Income Statement
INKT's Income by Division See INKT's Income by Division


INKT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions -14 -20 -18 0 24
Y / Y Investment Growth - - - - -
Net Income in Millions -12 -11 -22 -28 -30
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -127.07 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INKT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INKT's Competitors
Subscribers only: Roi for Mink Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for INKT's Customers

Other Ratios
INKT's Roa INKT's Inventory Turnover Ratio INKT's Growth Rates INKT's Dividend Statistics
INKT's Profitability Ratios INKT's Asset Turnover Ratio INKT's Dividend Growth
INKT's Roe INKT's Valuation Ratios INKT's Financial Strength Ratios INKT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Stablecoin Development Corporation  428.88 %
Vor Biopharma Inc   293.36 %
Elutia Inc   152.93 %
Arbutus Biopharma Corp  120.80 %
Indivior Pharmaceuticals Inc   108.22 %
Lensar Inc   94.32 %
Exelixis Inc   75.01 %
Advanced Biomed Inc.  70.51 %
Ironwood Pharmaceuticals inc   68.68 %
Rigel Pharmaceuticals Inc  68.50 %
Alnylam Pharmaceuticals Inc   63.14 %
Idexx Laboratories Inc  52.51 %
Elite Pharmaceuticals Inc   51.09 %
Oramed Pharmaceuticals Inc  48.08 %
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %

Date modified: 2026-11-13T23:38:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.